ISRCTN ISRCTN40367841
DOI https://doi.org/10.1186/ISRCTN40367841
Protocol serial number 13281
Sponsor Oxford University (UK)
Funder Wellcome Trust (UK)
Submission date
17/10/2012
Registration date
17/10/2012
Last edited
05/05/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Christy Toms
Scientific

University of Oxford
Department of Primary Health Care
Institute of Health Sciences
Old Road
Headington
Oxford
OX3 7LF
United Kingdom

Email christy.toms@dphpc.ox.ac.uk

Study information

Primary study designInterventional
Study designRandomised interventional process of care study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA pilot study and randomised trial of a multicomponent mobile-health based intervention compared with usual care to improve outcomes in chronic obstructive pulmonary disease
Study objectivesChronic obstructive pulmonary disease (COPD) is a chronic respiratory condition that affects 210 million people globally and an estimated 3 million people in the UK alone. COPD is a progressive disease without cure and it is estimated that COPD will become the third leading cause of death worldwide by 2020. The potential of mHealth technology in providing updates on patient status without the need for home visiting may offer opportunities for providing greater support than currently available for COPD patients. The mHealth system incorporates support for all aspects of care currently provided through personalised treatment plans, educational material in the form of videos and access to medical and medication records, to increase the impact of measures to improve care already in place. The system also includes a monitoring module allowing oxygen saturation measurement and a symptom diary with trend analysis to allow both patients and clinicians to identify deterioration. The sElf management anD support proGrammE (EDGE) for COPD is a clinical trial to evaluate the efficacy of an mHealth application used with a community respiratory nurse service to support patients with moderate to severe COPD in improving quality of life in comparison with usual care. There will be a pilot phase to refine the intervention and measures in preparation for the main trial.
Ethics approval(s)South Central -– Berkshire research ethics committee, ref: 12/SC/0437
Added 21/11/2013: ethical approval granted for amended criteria by South Central -– Berkshire research ethics committee on 09/05/2013
Health condition(s) or problem(s) studiedChronic obstructive pulmonary disease.
InterventionAn mHealth system to monitor health and provide additional educational support compared to usual care
Intervention typeOther
Primary outcome measure(s)

St George's Respiratory Questionnaire for COPD patients (SGRQ-C) measured at baseline, six months and twelve months

Key secondary outcome measure(s)

No secondary outcome measures

Completion date30/01/2015

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration295
Key inclusion criteriaCurrent inclusion criteria as of 21/11/2013:
1. Aged > 40 years
2. A forced expiratory volume in 1 second (FEV1) post-bronchodilatory <80% AND predicted ratio of FEV1 to forced vital capacity (FVC) <0.70 OR clinical decision of suitability for patients who are unable to provide a spirometry reading (on clinical grounds) at full assessment. The patient must have prior clinical evidence of COPD, i.e. obstructive spirometry within the last ten years; radiological evidence of emphysema.
3. Smoking history > 10 pack years
4. MRC Dyspnoea scale >or = to 2
5. Registered with a general practice and with an exacerbation of COPD requiring hospital admission or home treatment in the previous year, or referred for pulmonary rehabilitation
6. Absence of other significant lung disease
7. Absence of chronic heart failure defined by the New York Heart Association classification system as severe (Grade IV)
8. Able to give informed consent
9. Able to complete questionnaires and use the mHealth system
10. Life expectancy of >3 months
11. No recent participation in a COPD self-management clinical trial programme
12. Patients unable to transmit data from the tablet due to insufficient internet access will not be eligible to enter the study

Previous inclusion criteria:
1. Aged > 40 years
2. Forced expiratory volume in 1s (FEV1) post-bronchodilatory <70%
3. Predicted ratio of FEV1 to forced vital capacity (FVC) <0.70
4. Smoking history > 10 pack years
5. MRC Dyspnoea scale >or = to 2
6. Registered with a general practice and with an exacerbation of COPD requiring hospital admission or home treatment in the previous year, or referred for pulmonary rehabilitation
7. Absence of other significant lung disease
8. Absence of chronic heart failure
9. Able to give informed consent
10. Able to complete questionnaires and use the mHealth system
11. Life expectancy of >3 months
12. No recent participation in a COPD self-management clinical trial programme
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment05/11/2012
Date of final enrolment30/01/2015

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

University of Oxford
Oxford
OX3 7LF
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 07/03/2017 Yes No
Results article results 03/05/2017 Yes No
Protocol article protocol 08/01/2014 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

05/05/2017: Publication reference added.
09/03/2017: Publication reference added.